The clinical usefulness of the CTS5 in the prediction of late distant recurrence in postmenopausal women with estrogen receptor-positive early breast cancer

BACKGROUND: Clinical Treatment Score post-5 years (CTS5) is a promising prognostic tool to evaluate late distant recurrence (DR) risk for breast cancer after 5-year adjuvant endocrine therapy. PATIENTS AND METHODS: Among 560 postmenopausal women with pathological stage I–III estrogen receptor-positi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer
Main Authors: Tajiri, Wakako, Ijichi, Hideki, Takizawa, Katsumi, Koi, Yumiko, Masuda, Takanobu, Ueo, Hiroki, Koga, Chinami, Nakamura, Yoshiaki, Taguchi, Kenichi, Okamoto, Masahiro, Tokunaga, Eriko
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Japan 2020
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796868/
https://ncbi.nlm.nih.gov/pubmed/32601800
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12282-020-01130-y
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados